Pfizer‘s late-stage coronavirus vaccine trial has enrolled more than 42,000 volunteers, the company announced Tuesday when it released a mixed third-quarter earnings report.
Nearly 36,000 of the volunteers have already received the second of the company’s two-dose Covid-19 vaccine, the company said.
This is a developing story. Please check back for updates.
View original post